News Janssen/AbbVie drug approved in graft-versus-host disease First use for Imbruvica outside blood cancer.
News Takeda begins new R&D link-up with Molecular Templates Takeda is increasing its R&D investment in oncology with a collaboration with Texas biotech Molecular Templates.
News BMS snaps up cancer biotech IFM in $2.3bn deal BMS will gain rights to preclinical cancer immunotherapy drugs.
News NICE recommends Celgene pancreatic cancer drug Abraxane finally gets NHS funding following price cut.
News Scottish firm gets EU funding for 'off the shelf' cancer cel... First patients could be treated in 2019.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
